COX-2 selective inhibitor inhibits osteoclast differentiation

被引：0
|
作者：
Ryu, Kakei [1 ]
Amano, Hitoshi [2 ]
Iwai, Shinichi [1 ]
Emori, Haruka [1 ]
Yamada, Shoji [2 ]
Oguchi, Katsuji [1 ]
机构：
[1] Showa Univ, Sch Med, Dept Pharmacol, Shinagawa Ku, Tokyo 1428555, Japan
[2] Showa Univ, Sch Dent, Dept Pharmacol, Shinagawa Ku, Tokyo 1428555, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：171P / 171P
页数：1
相关论文
共 50 条
  • [21] L-745,337, A SELECTIVE COX-2 INHIBITOR
    PRASIT, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 272 - MEDI
  • [22] Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor
    Patrignani, P
    Capone, ML
    Tacconelli, S
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (02) : 265 - 284
  • [23] Meloxicam, a selective COX-2 inhibitor, in the therapy of postoperaive pain
    Loncar-Stojiljkovic, D
    Stojiljkovic, MP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (11) : A228 - A228
  • [24] The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis
    Schiffmann, Susanne
    Sandner, Jessica
    Schmidt, Ronald
    Birod, Kerstin
    Wobst, Ivonne
    Schmidt, Helmut
    Angioni, Carlo
    Geisslinger, Gerd
    Groesch, Sabine
    JOURNAL OF LIPID RESEARCH, 2009, 50 (01) : 32 - 40
  • [25] Lumiracoxib: More than just a selective COX-2 inhibitor
    Castanda-Hernandez, Gilberto
    Ortiz, Mario
    Granados-Soto, Vinicio
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 84 - 84
  • [26] Second selective COX-2 inhibitor receives marketing approval
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (13) : 1294 - 1294
  • [27] Etodolac (Lodine®): Profile of an established selective COX-2 inhibitor
    Richard A. Jones
    InflammoPharmacology, 2001, 9 (1-2) : 63 - 70
  • [28] Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyeritis through COX-2 independent pathway
    Miyamoto, Katsuichi
    Miyake, Sachiko
    Kusunoki, Susumu
    Yamamura, Takashi
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 117 - 118
  • [29] The 2′-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor
    Blobaum, Anna L.
    Uddin, Md Jashim
    Felts, Andrew S.
    Crews, Brenda C.
    Rouzer, Carol A.
    Marnett, Lawrence J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (05): : 486 - 490
  • [30] Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
    Saito, T
    Rodger, I
    Shennib, H
    Hu, F
    Tayara, L
    Giaid, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 114 - 119
12345